FDA Inspection 1029954 — Samir Mehmedagic, M.D., Clinical Investigator
The FDA completed an inspection of Samir Mehmedagic, M.D., Clinical Investigator on Sep 15, 2017 in Sarajevo. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 15, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Sarajevo (Bosnia-Hercegovina)
Additional details
Clinical Investigator (CI)